UPDATE 2-S.Korea's Samsung BioLogics says partner to boost stake in JV at heart of probe

SEOUL, May 18 (Reuters) – South Korean contract drugmaker Samsung BioLogics Co Ltd said on Friday U.S.-based Biogen Inc has offered to sharply …

Read More from the Source

Leave a Reply

Your email address will not be published. Required fields are marked *

%d bloggers like this: